Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.
Event Date | Tue Oct 31 EDT - Wed Nov 1 EDT (about 1 year ago) |
Location | Virtual Event |
Region | All |
Why attend?
This conference is an annual event addressing the country's most pressing policy issues in health and social care.
Through panels, live interviews, speeches and debates, you will hear insights from experts, politicians and industry leaders. We will examine topics including health inequalities, the role of data and technology in the NHS and how we can combat health misinformation.
Join us to hear insights from experts, politicians and industry leaders; network with fellow influential guests and address the most pressing healthcare issues facing the UK.
Key Themes
The year began with nurses’ strikes, which served to underline the struggles that the NHS faces, including staff shortages, insufficient capacity and a post-Covid backlog. A two-tier system is fast emerging in the UK, in which those who can afford private healthcare pay, while others languish on waiting lists and our social care systems are overburdened. However, health and care provision has come a long way since the pandemic began, with the crisis serving as a catalyst for innovation. As well as significant challenges, there are also opportunities that, together, we can grasp to build a high-quality, resilient health and care system. Our conference explores what all of this means for what is arguably the country’s most pressing policy issue: the future of UK healthcare. Key themes this conference will cover include:
• 75 years of the NHS: What works, what doesn’t and what's next?
• How can the life sciences sector work with the NHS to innovate and improve population health?
• How can we support a sustainable, resilient social care system?
• How can we tackle health inequalities and improve outcomes for people in disadvantaged areas in the UK?
• The future is digital: How can data, technology and virtual services improve healthcare provision?
• How can we leverage life sciences R&D to improve treatments and patient outcomes?
2023 Speakers
Karin Smyth MP
Shadow Health Minister and Member of Parliament for Bristol South
Sir David Haslam
Writer, healthcare policy consultant and past Chair of the National Institute for Health and Care Excellence (NICE)
Chi Onwurah MP
Shadow Minister for Science, Research and Innovation
Steve Brine MP
Chair of the Health and Social Care Select Committee
Lord Bethell
Former Minister for Innovation
Baroness Andrews of Southover OBE
Former Chair of the Lords Adult Social Care Committee
Daisy Cooper MP
Deputy Leader, Liberal Democrats
Debbie Abrahams MP
Chair of the APPG for Health in All Policies
Sir David Sloman
Former Chief Operating Officer, NHS England
Professor Vic Rayner OBE
Chief Executive Officer, National Care Forum
Rosalind Campion
Director, Office for Life Sciences
Rachel Power
Chief Executive, Patients Association
Ming Tang
Chief Data and Analytics Officer, NHS England
Dr Mubasshir Ajaz
Head of Health and Communities, West Midlands Combined Authority
Andrew Harrop
General Secretary, Fabian Society
Paul Blakeley
Senior Policy Adviser, Tony Blair Institute for Global Change
Kate Lee
Chief Executive, Alzheimer's Society
Vishaal Virani
Head of Health, YouTube
Dr Ursula Montgomery
Head of Healthcare Government Affairs, Bayer UK
Alan How
Digital Pharma Commercial Lead, UK & Ireland, Bayer UK
Kylie Bromley
Vice President and Managing Director, Biogen UK and Ireland
Jagtar Dhanda
Director of Policy, Advocacy and Government Affairs, BMS UK & Ireland
Professor Sultan Mahmud
Director of Healthcare, BT
Clare Pelham
Chief Executive, Epilepsy Society
Simon Newton
UK and Ireland General Manager, Jazz Pharmaceuticals
Jennifer Blainey
Director of Government Affairs, Novavax UK and Ireland
Paul McIntosh
Country Director, Novavax UK and Ireland
Susan Rienow
Country President, Pfizer UK
Phil Whitaker
Medical Editor, New Statesman
Alona Ferber
Senior Editor, New Statesman Spotlight
Will Dunn
Business Editor, New Statesman
Sarah Dawood
Senior Associate Editor, New Statesman Spotlight
Zoë Grünewald
Policy and Politics Correspondent, New Statesman
Harry Clarke-Ezzidio
Policy Reporter, New Statesman
Jon Bernstein
Former Deputy Editor, New Statesman
2023 Sponsors
ASSOCIATE SPONSORS:
• Bayer
• Biogen
• Bristol Myers Squibb
• Epilepsy Society
• Jazz Pharmaaceuticals
• Novavax
• Pfizer
• Wellcome